Aim: The aim
was to determine prognostic factors effecting clinical course of the patients
referring to the Child Emergency Service in our hospital with valproic acid
(VPA) poisoning.
Method:
Patients who had VPA poisoning diagnoses between 2010 and 2016 in our Child Emergency
Service were retrospectively examined. Demographical characteristics, clinical
findings, laboratory results, treatment methods and effective factors for
prognosis were evaluated for the patients.
Findings:
114 patients were included in the study. Average age of the patients was
9.91±4.69 years. Sixty-six of the patients were female and forty-eight were
male. The most common reason for inclusion was overdosing (100 patients,
87.72%). Fourteen patients (12.28%) had pure VPA poisoning. VPA serum level
median value was 141.80 µ/mL (min-max;
102.20 – 640.38 µ/mL). Central nervous system depression was the most common
clinical finding (six patients, 5.2%). Thrombocytopenia was detected in sixteen
patients (14.0%) and hyperammoniemia in eighteen patients (15.8%). Average
follow-up duration for the patients was 16.14 hours. L-carnitine treatment was
applied for six patients (5.3%).
Result: In
long-term VPA usage, the importance of thrombocytopenia and ammonia level on
prognosis shouldn't be forgotten. Supportive
treatment still maintains its importance in VPA intoxication and intensive care
follow-up and treatment was necessary for two patients in our study and L
carnitine was started for patients with suitable indications and preserves its
importance in treatment.
Amaç: Çocuk Acil Servisimize valproik
asit(VPA) zehirlenmesi tanısı ile başvuran hastaların klinik seyrini etkileyen
prognostik faktörlerin belirlenmesi amaçlanmıştır.
Yöntem: Çocuk Acil Servisimize
2010-2016 yılları arasında VPA zehirlenme tanısı alan hastalar geriye dönük
incelendi. Hastaların, demografik özellikleri, klinik bulguları, laboratuar
sonuçları, tedavi yöntemleri ve prognozda etkili faktörler değerlendirildi.
Bulgular: Çalışmaya 114 hasta dahil
edildi. Hastaların yaş ortalaması 9,91±4,69 yıl idi. Hastaların 66’sı kız ve 48’i
erkekti. Alım nedenleri arasında en sık neden doz aşımı (100 hasta, %87,72)
idi. 14 hasta (%12,28) ise suisidal saf VPA zehirlenmesi idi. VPA serum düzeyi
ortanca değeri 141,80 µ/mL (min-max; 102,20
– 640,38 µ/mL) idi. En sık klinik bulgu (6 hasta, %5,2) santral sinir sistemi
depresyonu mevcuttu. On altı hastada (%14,0) trombostopeni ve 18 hastada (%15,8)
hiperamonyemi tespit edildi. Hastaların ortalama takip süresi 16,14 saat idi. Altı
hastaya (% 5,3) L-karnitin tedavisi uygulandı.
Sonuç: Uzun dönem VPA kullanımında trombositopeni ve amonyak seviyesininde
prognozdaki yeri unutulmamalıdır.
VPA intoksikasyonunda destekleyici tedavi halen önemini korumakta olup
çalışmamızda 2 hastamızda yoğun bakım takip ve tedavisi gerekmiş olup, L
carnitin uygun endikasyonlu hastalara
başlandı ve tedavide yerini korumaktadır.
Subjects | Health Care Administration |
---|---|
Journal Section | Articles |
Authors | |
Publication Date | March 21, 2017 |
Published in Issue | Year 2017 |